American Conference Institute's 21st National Conference on Consumer Finance Class Actions & Litigation
29 January 2015
Lawson will participate in the panel titled, “CFPB Enhanced Oversight and Heightened Scrutiny of the Industry: Evaluating Lessons Learned from Recent Enforcement Actions, Preparing for Investigations and Examinations and Looking Ahead to Rulemaking Updates.” Lawson, along with Donald Maurice of Maurice & Needleman, P.C., and Gerald Sachs of Paul Hastings LLP, will discuss an array of issues including:
- Assessing recent enforcement actions and investigations undertaken by the CFPB: Lessons learned; Trends in enforcement actions; Which market sectors are receiving enhanced scrutiny and why?; Pursuit of mortgage reinsurance cases
- Anticipating the types of claims that the CFPB will be pursuing in the near-term: Bulletin relating to mortgage servicing transfers: Which CFPB actions will lead to
piggybacking private actions? - Preparing for and responding to CFPB investigations
- Responding to CIDs (Civil Investigative Demands)
- Where the CFPB is likely headed in the coming months: Trends in examinations and investigations; What to expect
- Assessing coordination efforts between the CFPB and other federal and state agencies, including state AGs
- Rulemaking updates: Recent enforcement actions claiming ‘disparate impact’
- Impact of the CFPB’s consumer complaints database on consumer finance litigation: How have plaintiffs’ counsel responded?; How financial institutions can use the database
to anticipate and prepare for the next wave of litigation and develop proactive compliance strategies to minimize risk - Assessing the CFPB’s adjudication procedures
- Attorney-client privilege and the CFPB
For more information and to register for the event, visit the American Conference Institute’s website.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.